North America’s Largest Veterinary Internal Medicine Conference to Feature Animal Survivors of Life Threatening Diseases from Colorado

DENVER, Colo. " The American College of Veterinary Internal Medicine (ACVIM) will host the media briefing Animal Survivor during the 2011 ACVIM Forum on Thursday, June 16.

Animal Survivor will give media insight into the medical advances that saved the lives of courageous Denver-area animals and will allow reporters to meet the animals, the owners, and Board-certified Veterinary Specialists who were instrumental in their care.

WHAT: ANIMAL SURVIVOR " Sponsored by Abbott Animal Health & KCI Animal HealthAnimals, their owners, and the Veterinary Specialists who cared for the animals will share remarkable Animal Survivor stories at this event. The animals will serve as excellent visuals of local animals that have overcome life-threatening diseases thanks to the help of an ACVIM Board-certified Specialist. For more information, please visit www.WeAreAnimalSurvivors.org.

WHEN: Thursday, June 16; 9:50 am to 11:00 amACVIM Forum Press Room, Room 703, Colorado Convention CenterFor press credentials or more information, please contact Jenn Armbruster at 303-231-9933 x105, 720-289-3663, or Jennifer@ACVIM.org.

WHO: The American College of Veterinary Internal Medicine (ACVIM) believes in longer, healthier lives for us all. Every day, we help foster the important work being done by our members, allowing them to prevent, treat, and cure diseases in animals – – and humans – – including cancer, heart disease, seizures, and diabetes. The ACVIM hosts an annual continuing education meeting (ACVIM Forum) where cutting-edge information, technology, and research abstracts are showcased for the veterinary community. For more information, please visit www.ACVIM.org or www.ACVIMForum.org.

# # #

The mission of the American College of Veterinary Internal Medicine (ACVIM)is to enhance animal and human health by advancing veterinary internal medicine through training, education, and discovery.

Share.

Comments are closed.